Breaking News
December 10, 2018 - UC San Diego professor receives NCI Outstanding Investigator Award for cancer research
December 10, 2018 - Study evaluates placental mesenchymal stem cell sheets for myocardial repair and regeneration
December 10, 2018 - Blueprint Medicines Announces Updated Results from Ongoing EXPLORER Clinical Trial of Avapritinib Demonstrating Broad Clinical Activity and Significant Symptom Reductions in Patients with Systemic Mastocytosis
December 10, 2018 - Study clarifies ApoE4’s role in dementia
December 10, 2018 - Neuronal activity in the brain allows prediction of risky or safe decisions
December 10, 2018 - FDA Alerts Health Care Professionals and Patients Not to Use Drug Products Intended to be Sterile from Promise Pharmacy
December 10, 2018 - Improving dementia care and treatment saves thousands of pounds in care homes
December 10, 2018 - Heroin-assisted treatment can offer benefits, reduce harms
December 10, 2018 - People covered by Michigan’s expanded Medicaid program report improvements in health, finds study
December 10, 2018 - Hazelnuts improve micronutrient levels in older adults
December 9, 2018 - History of Partner Violence Tied to Menopause Symptoms
December 9, 2018 - Clean Up Safely After a Disaster|Natural Disasters and Severe Weather
December 9, 2018 - Drug wholesalers drove fentanyl’s deadly rise, report concludes
December 9, 2018 - Deprescribing could help manage polypharmacy in older adults
December 9, 2018 - Retraction of article “Joy of cooking too much” from journal
December 9, 2018 - FDA Warns of Rare Stroke Risk With MS Drug Lemtrada (Alemtuzumab)
December 9, 2018 - Feds say heroin, fentanyl remain biggest drug threat to US
December 9, 2018 - Eliminating microglia can reverse some aspects of stress sensitization, study shows
December 9, 2018 - New genetic insight could help treat rare debilitating heart and lung condition
December 9, 2018 - MiRagen Therapeutics Announces Final Safety, Biodistribution and Clinical Efficacy Data From Phase 1 Cobomarsen Clinical Trial in Patients With Mycosis Fungoides
December 9, 2018 - Work with your doctor to weigh pros, cons of treatment options for hyperthyroidism
December 9, 2018 - CWRU researcher secures $14.6 million funding for genetic study into Alzheimer’s disease
December 9, 2018 - High intensity statin treatment and adherence could save more lives
December 9, 2018 - Surgery patients use only 1/4 of prescribed opioids, and prescription size matters
December 9, 2018 - AXT offers Phi Optics upgrade to QPI systems for inverted light microscopes
December 9, 2018 - New booklet could help improve conditions of young pupils with albinism
December 9, 2018 - Few Physicians Work in Practices That Use Telemedicine
December 9, 2018 - Older Adults and Oral Health
December 9, 2018 - Health utility values improve after septorhinoplasty
December 9, 2018 - New EU-funded project provides insight into how the brain develops
December 9, 2018 - Expanded use of tele-emergency services can help strengthen rural hospitals
December 9, 2018 - Infections in the Young May Be Tied to Risk for Mental Illness: Study
December 9, 2018 - Profile: Native Hawaiians and Pacific Islanders
December 9, 2018 - Snoring poses greater cardiac risk to women
December 9, 2018 - Researcher takes further steps in understanding how and why cute aggression occurs
December 9, 2018 - Researchers create new light-activated tools for controlling neurons
December 9, 2018 - Spinal cord injury disrupts the body’s internal clock, study shows
December 9, 2018 - Babies recognize nested structures similar to our grammar
December 9, 2018 - UT Austin researcher receives $2.5 million CZI grant for neurodegenerative disease research
December 9, 2018 - Sleep problems found to be prevalent and increasing among college students
December 9, 2018 - Study reveals why some children are susceptible to the effects of maltreatment
December 9, 2018 - Study investigates influence of different opioids on driving performance
December 9, 2018 - Jazz Pharmaceuticals Announces First Patient Enrolled in Phase 3 Clinical Trial Evaluating JZP-258 for the Treatment of Idiopathic Hypersomnia
December 9, 2018 - Eliminating microglia prevents heightened immune sensitivity after stress
December 9, 2018 - Boys with social difficulties are at greatest risk of early substance use
December 9, 2018 - ‘Wrong’ connective tissue cells linked to worse prognosis in breast cancer patients
December 8, 2018 - Chronic, refractory schizophrenia patients benefit from targeted cognitive training
December 8, 2018 - Advertising in kids’ apps more prevalent than parents may realize
December 8, 2018 - New way to trace the transmission histories of rare genetic diseases
December 8, 2018 - ASH: A+CHP Bests CHOP for Peripheral T-Cell Lymphoma
December 8, 2018 - Results of pediatric genomic epilepsy tests often reclassified
December 8, 2018 - New way of controlling HIV latency to completely eradicate the virus
December 8, 2018 - Phasefocus to showcase the Livecyte 2 at ASCB
December 8, 2018 - KHN’s ‘What the Health?’ Is health spending the next big political issue?
December 8, 2018 - Mussels take in microplastic pollution fibers and flush most of them out again
December 8, 2018 - AHA: How to Stop Smoking … for Good
December 8, 2018 - Scientists overturn odds to make Parkinson’s discovery
December 8, 2018 - Health benefits of producing marula vinegar
December 8, 2018 - Failure of critical cellular energy sensor responsible for CKD progression, study finds
December 8, 2018 - Ethnicity can be reliable indicator of gut microbiota diversity
December 8, 2018 - Safe Sleep for Baby | NIH News in Health
December 8, 2018 - Study looks at ways technology can support nutritional needs of Parkinson’s patients
December 8, 2018 - Infant milk allergy is being overdiagnosed say experts
December 8, 2018 - Graphene may one day be used to test for ALS
December 8, 2018 - Houston Methodist launches real-time website to track flu cases
December 8, 2018 - RedHill Announces Positive Top-Line Results from Confirmatory Phase 3 Study with Talicia for H. pylori Infection
December 8, 2018 - A way to measure obesity and health beyond BMI
December 8, 2018 - New diagnostic tools may help identify breast cancer patients who could benefit from targeted therapies
December 8, 2018 - Duke-NUS researchers highlight possible role of bioaerosol sampling in pandemic surveillance
December 8, 2018 - Study quantifies links between alcohol, drug use and violent deaths
December 8, 2018 - Mothers’ stress levels at conception linked to child’s response to life challenges at age 11
December 8, 2018 - MIT researchers develop antimicrobial peptides from South American wasp’s venom
December 8, 2018 - Obesity prevention among low-income, diverse preschool-aged children and parents
December 8, 2018 - Mount Sinai researcher awarded $2.5 million to advance understanding of neurodegenerative diseases
December 8, 2018 - CZI announces funding for open-source software efforts to improve image analysis in biomedicine
December 8, 2018 - New book encompasses the vast history of reproduction
December 8, 2018 - Low-income women in Texas are not receiving contraception after childbirth, study shows
December 8, 2018 - Study expands knowledge about sexuality and gender gaps in political attitudes
December 8, 2018 - Drug reduces hot flash frequency, improves quality of life in breast cancer survivors
December 8, 2018 - Imaging, Biopsy Often Still Needed After Mastectomy
Study reveals factors linked to the development of Crohn’s disease

Study reveals factors linked to the development of Crohn’s disease

image_pdfDownload PDFimage_print

How cells talk to each other, and what they say, has long held fascination for Seema Khurana, professor of biology and biochemistry. Recently Gastroenterology Journal published her findings about how defects in the conversations between actin molecules and the protein EIF2A (that warns of incoming cellular stress) are linked to the development of Crohn’s disease.

Now with a new $2.3 million grant from the National Institute of Diabetes and Digestive and Kidney Diseases, Khurana will continue monitoring cellular cross talk to find new targets for drug development that could push Crohn’s into remission.

“Current treatments of Crohn’s disease are expensive, associated with significant side effects and induce remission in only a little over half of the patients,” said Khurana. “What causes Crohn’s disease remains poorly understood, and the treatment approaches are limited.”

That leaves room for researchers to hone in deeply to where the disease might gain access to the gastrointestinal tract, through the lining of gastrointestinal cells called the actin cytoskeleton. It is now considered a molecular pathway involved in the development of the disease.

“We discovered that actin is a sensor of cell stress, so if there’s a defect in the sensor and it can’t sense danger, it can’t communicate to warn the cell to adapt. Alternatively, the sensors can be abnormally and chronically activated,” said Khurana, who examined stem cells isolated from Crohn’s disease patients to study these defects in cell stress signaling. When cultured in the laboratory, these stem cells form mini guts that maintain most of the defects seen in the intestinal tissue of Crohn’s disease patients.

The number of people with Crohn’s disease, a chronic, relapsing inflammatory bowel disease, is rising across all ethnic and age groups, with as many as 70,000 new cases diagnosed every year in the United States. Patients with Crohn’s are also at risk for small intestine and colorectal cancer.

“Our unique findings reveal that in intestinal epithelial cells, acute changes in actin dynamics modulate the cell stress response determining which cells survive and which die, influencing signaling that is pivotal to inflammation and Crohn’s disease development,” said Khurana. Under particular scrutiny are villin and gelsolin, two actin-binding cytoskeletal proteins in the intestine that Khurana has already found precipitate changes in actin.

Using samples from people with Crohn’s disease, Khurana will identify new targets for medication that could reduce inflammation in the gastrointestinal tract while at the same time testing existing medications, already approved by the U.S. Food and Drug Administration for other ailments, for the treatment of Crohn’s. To examine the cells, Khurana is using a new experimental approach combining in vitro (in a glass) studies in intestinal epithelial cells, culturing stem cells isolated from patient biopsies and cultured ex vivo (outside the living organism) as mini-guts, as well as in vivo (inside the living organism) studies using state-of-the-art approaches.

“In addition to conceptual and translational innovation, this study also provides technological innovation by demonstrating that stem cells from patients can be used in the laboratory to generate mini guts to test potential new therapies or drug cocktails in order to provide effective, targeted individual therapy to patients with Crohn’s disease,” said Khurana.

Her work stands at the intersection of pathology, which describes disease states, and physiology, which describes the processes operating inside an organism.

“Our long-term goal is to provide a better understanding of the pathophysiology of Crohn’s disease,” she said. “We believe our studies will advance scientific discovery, and in the future, permit rapid translation of basic science to model new therapies which could advance patient care.”

Source:

http://www.uh.edu/news-events/stories/2018/october-2018/100218-khurana-crohns-disease.php

Tagged with:

About author

Related Articles